503 related articles for article (PubMed ID: 24434293)
1. Preclinical evaluation of 68Ga-labeled 1,4,7-triazacyclononane-1,4,7-triacetic acid-ubiquicidin as a radioligand for PET infection imaging.
Ebenhan T; Zeevaart JR; Venter JD; Govender T; Kruger GH; Jarvis NV; Sathekge MM
J Nucl Med; 2014 Feb; 55(2):308-14. PubMed ID: 24434293
[TBL] [Abstract][Full Text] [Related]
2. Peptide synthesis, characterization and ⁶⁸Ga-radiolabeling of NOTA-conjugated ubiquicidin fragments for prospective infection imaging with PET/CT.
Ebenhan T; Chadwick N; Sathekge MM; Govender P; Govender T; Kruger HG; Marjanovic-Painter B; Zeevaart JR
Nucl Med Biol; 2014; 41(5):390-400. PubMed ID: 24630816
[TBL] [Abstract][Full Text] [Related]
3.
Ebenhan T; Sathekge MM; Lengana T; Koole M; Gheysens O; Govender T; Zeevaart JR
J Nucl Med; 2018 Feb; 59(2):334-339. PubMed ID: 29051342
[TBL] [Abstract][Full Text] [Related]
4. ⁶⁸Ga-NOTA-UBI-29-41 as a PET Tracer for Detection of Bacterial Infection.
Vilche M; Reyes AL; Vasilskis E; Oliver P; Balter H; Engler H
J Nucl Med; 2016 Apr; 57(4):622-7. PubMed ID: 26769861
[TBL] [Abstract][Full Text] [Related]
5. 99mTc-labeled antimicrobial peptide ubiquicidin (29-41) accumulates less in Escherichia coli infection than in Staphlococcus aureus infection.
Akhtar MS; Iqbal J; Khan MA; Irfanullah J; Jehangir M; Khan B; Ul-Haq I; Muhammad G; Nadeem MA; Afzal MS; Imran MB
J Nucl Med; 2004 May; 45(5):849-56. PubMed ID: 15136636
[TBL] [Abstract][Full Text] [Related]
6. (68)Ga-radiopharmaceuticals for PET imaging of infection and inflammation.
Kumar V; Boddeti DK
Recent Results Cancer Res; 2013; 194():189-219. PubMed ID: 22918761
[TBL] [Abstract][Full Text] [Related]
7. Preparation of a promising angiogenesis PET imaging agent: 68Ga-labeled c(RGDyK)-isothiocyanatobenzyl-1,4,7-triazacyclononane-1,4,7-triacetic acid and feasibility studies in mice.
Jeong JM; Hong MK; Chang YS; Lee YS; Kim YJ; Cheon GJ; Lee DS; Chung JK; Lee MC
J Nucl Med; 2008 May; 49(5):830-6. PubMed ID: 18413379
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, preclinical validation, dosimetry, and toxicity of 68Ga-NOTA-anti-HER2 Nanobodies for iPET imaging of HER2 receptor expression in cancer.
Xavier C; Vaneycken I; D'huyvetter M; Heemskerk J; Keyaerts M; Vincke C; Devoogdt N; Muyldermans S; Lahoutte T; Caveliers V
J Nucl Med; 2013 May; 54(5):776-84. PubMed ID: 23487015
[TBL] [Abstract][Full Text] [Related]
9.
Mukherjee A; Bhatt J; Shinto A; Korde A; Kumar M; Kamaleshwaran K; Joseph J; Sarma HD; Dash A
J Pharm Biomed Anal; 2018 Sep; 159():245-251. PubMed ID: 29990892
[TBL] [Abstract][Full Text] [Related]
10. Gallium-68 labeled Ubiquicidin derived octapeptide as a potential infection imaging agent.
Bhatt J; Mukherjee A; Shinto A; Koramadai Karuppusamy K; Korde A; Kumar M; Sarma HD; Repaka K; Dash A
Nucl Med Biol; 2018; 62-63():47-53. PubMed ID: 29883883
[TBL] [Abstract][Full Text] [Related]
11. Radiolabeling and Preliminary Evaluation of Ga-68 Labeled NODAGA-Ubiquicidin Fragments for Prospective Infection Imaging.
Bhatt J; Mukherjee A; Korde A; Kumar M; Sarma HD; Dash A
Mol Imaging Biol; 2017 Feb; 19(1):59-67. PubMed ID: 27406090
[TBL] [Abstract][Full Text] [Related]
12. Evaluating the potential of kit-based 68Ga-ubiquicidin formulation in diagnosis of infection: a pilot study68Ga.
Bhusari P; Bhatt J; Sood A; Kaur R; Vatsa R; Rastogi A; Mukherjee A; Dash A; Mittal BR; Shukla J
Nucl Med Commun; 2019 Mar; 40(3):228-234. PubMed ID: 30480552
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of
Boddeti DK; Kumar V
World J Nucl Med; 2021; 20(3):266-272. PubMed ID: 34703395
[TBL] [Abstract][Full Text] [Related]
14. Development of a New Folate-Derived Ga-68-Based PET Imaging Agent.
Brand C; Longo VA; Groaning M; Weber WA; Reiner T
Mol Imaging Biol; 2017 Oct; 19(5):754-761. PubMed ID: 28194631
[TBL] [Abstract][Full Text] [Related]
15. Imaging of bacterial infection: Harnessing positron emission tomography and Cherenkov luminescence imaging with UBI-derived octapeptide.
Mitra JB; Mukherjee A; Kumar A; Chandak A; Rakshit S; Yadav HD; Pandey BN; Sarma HD
Drug Dev Res; 2023 Nov; 84(7):1513-1521. PubMed ID: 37571805
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and evaluation of a novel 68Ga-chelate-conjugated bisphosphonate as a bone-seeking agent for PET imaging.
Suzuki K; Satake M; Suwada J; Oshikiri S; Ashino H; Dozono H; Hino A; Kasahara H; Minamizawa T
Nucl Med Biol; 2011 Oct; 38(7):1011-8. PubMed ID: 21982572
[TBL] [Abstract][Full Text] [Related]
17. Infection detection in mice using 99mTc-labeled HYNIC and N2S2 chelate conjugated to the antimicrobial peptide UBI 29-41.
Welling MM; Visentin R; Feitsma HI; Lupetti A; Pauwels EK; Nibbering PH
Nucl Med Biol; 2004 May; 31(4):503-9. PubMed ID: 15093821
[TBL] [Abstract][Full Text] [Related]
18. N-terminal modifications improve the receptor affinity and pharmacokinetics of radiolabeled peptidic gastrin-releasing peptide receptor antagonists: examples of 68Ga- and 64Cu-labeled peptides for PET imaging.
Gourni E; Mansi R; Jamous M; Waser B; Smerling C; Burian A; Buchegger F; Reubi JC; Maecke HR
J Nucl Med; 2014 Oct; 55(10):1719-25. PubMed ID: 25146125
[TBL] [Abstract][Full Text] [Related]
19. Preclinical Assessment of a
Ebenhan T; Mokaleng BB; Venter JD; Kruger HG; Zeevaart JR; Sathekge M
Molecules; 2017 Aug; 22(9):. PubMed ID: 28837117
[TBL] [Abstract][Full Text] [Related]
20. Imaging of human epidermal growth factor receptor type 2 expression with 18F-labeled affibody molecule ZHER2:2395 in a mouse model for ovarian cancer.
Heskamp S; Laverman P; Rosik D; Boschetti F; van der Graaf WT; Oyen WJ; van Laarhoven HW; Tolmachev V; Boerman OC
J Nucl Med; 2012 Jan; 53(1):146-53. PubMed ID: 22173842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
